Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan
Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan
复制标题
DOI：
10.1111/j.1442-2042.2008.02125.x
复制
发表时间：
2008-09-01
影响因子：
2.6
通讯作者：
Okuyama, Akihiko
中科院分区：
文献类型：
--
作者：
Ito, Kazuto;Kakehi, Yoshiyuki;Okuyama, Akihiko
与美国或西欧相比，日本使用前列腺特异性抗原（PSA）筛查前列腺癌的暴露率仍然很低。前列腺癌的死亡率将在未来增加，到2020年将是2000年的2.8倍。因此，迫切需要确定降低前列腺癌死亡率的最佳对策。
The exposure rate of screening for prostate cancer using prostate-specific antigen (PSA) in Japan is still very low compared with that in the USA or Western Europe. The mortality rate of prostate cancer will increase in the future and in 2020 it will be 2.8 times higher than in 2000. Therefore, there is an urgent need to determine the best available countermeasures to decrease the rate of prostate cancer death.